Federal contract award
75N95022C00004
PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA NIDA REF. NO. N01DA-22-8959. BASE AWARD.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $4.8M |
| Current contract value | $4.8M |
| Potential contract value / ceiling | $7.7M |
| Start date | Feb 22, 2022 |
| Current end date | Feb 21, 2027 |
| Potential end date | Feb 21, 2027 |
| Latest award activity | Aug 11, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 11, 2026 | P00008 | $0 | EO14398. PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA; NIDA REF. NO. N01DA-22-8959. 02/22/2022 - 02/21/2027. |
| Jan 29, 2026 | P00007 | $784.1K | PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA; NIDA REF. NO. N01DA-22-8959. 02/22/2022 - 02/21/2027. |
| Aug 13, 2025 | P00006 | $-239.6K | EOI::IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA NIDA REF. NO. N01DA-22-8959. 02/22/2022 - 02/21/2026. |
| Feb 11, 2025 | P00005 | $1.1M | PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA; NIDA REF. NO. N01DA-22-8959. 02/22/2022 - 02/21/2026. |
| Sep 13, 2024 | P00003 | $0 | PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA; NIDA REF. NO. N01DA-22-8959. 02/22/2022 - 02/21/2025. |
| Sep 13, 2024 | P00004 | $92.0K | PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA; NIDA REF. NO. N01DA-22-8959. 02/22/2022 - 02/21/2025. |
| Feb 27, 2024 | P00002 | $1.1M | PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA; NIDA REF. NO. N01DA-22-8959. 02/22/2022 - 02/21/2025. |
| Feb 22, 2023 | P00001 | $1.0M | PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA; NIDA REF. NO. N01DA-22-8959. 02/22/2022 - 02/21/2024. |
| Feb 22, 2022 | 0 | $973.1K | PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA NIDA REF. NO. N01DA-22-8959. BASE AWARD. |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-02-21 (119 days from calculation)
- +35 points
- 173 historical awards in this buyer and category group
- +15 points
- 9 recorded award transactions
- +10 points
- Latest award action: 2026-08-11
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Alexander Beraud | Contact | alexander.beraud@nih.gov 3014436677 | Source | Nov 5, 2021 |
| Tracy Cain | Contact | tracy.cain@nih.gov 3014436677 | Source | Nov 5, 2021 |
| Alexander Beraud | Contact | alexander.beraud@nih.gov 3014436677 | Source | Oct 22, 2021 |
| Tracy Cain | Contact | tracy.cain@nih.gov 3014436677 | Source | Oct 22, 2021 |
| Alexander Beraud | Contact | alexander.beraud@nih.gov 3014436677 | Source | Aug 27, 2021 |
| Tracy Cain | Contact | tracy.cain@nih.gov 3014436677 | Source | Aug 27, 2021 |
| Alexander Beraud | Contact | alexander.beraud@nih.gov 3014436677 | Source | Aug 27, 2021 |
| Tracy Cain | Contact | tracy.cain@nih.gov 3014436677 | Source | Aug 27, 2021 |
| Alexander Beraud | Contact | alexander.beraud@nih.gov 3014436677 | Source | Jul 7, 2021 |
| Tracy Cain | Contact | tracy.cain@nih.gov 3014436677 | Source | Jul 7, 2021 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.